Multiple Sclerosis Fellowship
Leadership
- Program Director
- Multiple Sclerosis Fellowship Program
For Program Information
- Fellowship Program Coordinator
- Department of Neurology
901 Walnut Street
Suite 400
Philadelphia, PA 19107
The Comprehensive Multiple Sclerosis Center utilizes an integrated approach to diagnosis and treatment of Multiple Sclerosis and other neuroimmunological disorders.
It serves as a tertiary referral and teaching center and is allied with a multispecialty team of practitioners. It has special programs for clinically isolated syndromes, transverse myelitis, and spasticity management. Fellows have an opportunity to participate in ongoing clinical and ex vivo research into the immunology of neurological disorders, new treatment and diagnostic approaches, novel imaging modalities, and outcome and genetic studies in MS.
The Laboratory of Neuroimmunology offers qualified candidates further opportunities in basic and translational research in Multiple Sclerosis.
Recent Publications
- Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort
- Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment
- A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study
- A retrospective claims analysis of fatigue in patients with multiple sclerosis on disease-modifying therapy
- Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial